About Corlieve Therapeutics
Corlieve Therapeutics is a company based in Paris (France) founded in 2019 by Valerie Crepel, Christophe Mulle, and Richard Porter was acquired by UniQure in June 2021.. Corlieve Therapeutics offers products and services including Domain Registration, Web Hosting, Email Hosting, and VPS. Corlieve Therapeutics operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Paris, France
- Founders Valerie Crepel, Christophe Mulle, Richard Porter
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Corlieve Therapeutics
Corlieve Therapeutics offers a comprehensive portfolio of products and services, including Domain Registration, Web Hosting, Email Hosting, and VPS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for reserving and managing domain names online.
Platform for activating and using web hosting packages.
Solution for email management and hosting needs.
Virtual server for advanced hosting and customization.
Funding Insights of Corlieve Therapeutics
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Seed - Corlieve Therapeutics | Valuation | Kurma Partners , Idinvest Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Corlieve Therapeutics
Corlieve Therapeutics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include UniQure, Idinvest Partners and Kurma Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are funded through venture capital in life sciences.
|
Founded Year | Domain | Location | |
|
Equity investments are provided to low and middle market companies.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in innovative drug development companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Corlieve Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Corlieve Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Corlieve Therapeutics Comparisons
Competitors of Corlieve Therapeutics
Corlieve Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Corlieve Therapeutics
Frequently Asked Questions about Corlieve Therapeutics
When was Corlieve Therapeutics founded?
Corlieve Therapeutics was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Corlieve Therapeutics located?
Corlieve Therapeutics is headquartered in Paris, France.
Who is the current CEO of Corlieve Therapeutics?
Richard Porter is the current CEO of Corlieve Therapeutics. They have also founded this company.
What does Corlieve Therapeutics do?
Corlieve Therapeutics was founded in 2019 in Paris, France, within the biotechnology sector. Focus is placed on developing therapeutic solutions for neurological disorders through advanced drug delivery technologies. Gene therapy methods, supported by an AAV gene delivery platform, are utilized to address drug-resistant temporal lobe epilepsy. Operations center on innovative treatments for unmet medical needs in neurology.
Who are the top competitors of Corlieve Therapeutics?
Corlieve Therapeutics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Corlieve Therapeutics offer?
Corlieve Therapeutics offers Domain Registration, Web Hosting, Email Hosting, and VPS.
Who are Corlieve Therapeutics's investors?
Corlieve Therapeutics has 4 investors. Key investors include UniQure, Idinvest Partners, Kurma Partners, and Pureos Bioventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.